ARCT

Q: What is the price of Arcturus Therapeutics (ARCT) today?

The price of Arcturus Therapeutics (ARCT) today is R$ 95,07, with a variation of -18.19% compared to the last year. The price of Arcturus Therapeutics (ARCT) started the year trading around R$ 91,98 and today it is at R$ 95,07. Follow the real-time price chart, the historical price of Arcturus Therapeutics (ARCT), and stock data from Ibovespa and international markets.

Q: When does Arcturus Therapeutics (ARCT) pay dividends?

Arcturus Therapeutics (ARCT) did not distribute dividends in the last year.

Q: Arcturus Therapeutics (ARCT) is it worth it?

Currently, Arcturus Therapeutics (ARCT) is priced at R$ 95,07, with a P/E of -8,31%, representing a deviation of -11,65% from its historical average P/E. In the last year, the stock showed a variation of -18.19% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -18,19%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Arcturus Therapeutics (ARCT)?

Investing in shares of Arcturus Therapeutics (ARCT) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Arcturus Therapeutics (ARCT) yield today?

The yield of Arcturus Therapeutics (ARCT) was 17,40% in the last month, -18,19% in the last year and -66,46% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Arcturus Therapeutics (ARCT) today, the total investment would be based on the current price of R$ 95,07.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 7.777,41In 5 years: R$ 3.188,54In 10 years: 3.102,03It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Arcturus Therapeutics Holdings Inc.

Price

US$ 17,54

variation (12m)

-18,19%

p/l

-8,31

p/vp

2,16

DIVIDEND YIELD

0,00%

quote ARCT

BVMF

ARCT

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of ARCT

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

17,40%

3 months

48,39%

1 year

-18,19%

2 years

-44,39%

5 years

-66,46%

10 years

-67,37%

real profitability

profitability minus inflation.

1 month

17,40%

3 months

47,65%

1 year

-22,27%

2 years

-49,31%

5 years

-75,49%

10 years

-80,66%

Indicators ARCT

check out the fundamentals of Arcturus Therapeutics shares

P/L

-8,31

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

4,55

Sector: -3,77 Industry: -3,77

P/VP

2,16

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-19,45%

Sector: -63,50% Industry: -63,50%

ROE

-26,04%

Sector: -67,23% Industry: -67,23%

ROIC

-51,59%

Sector: -2.087,74% Industry: -2.087,74%

Net Margin

-54,79%

Sector: -43,34% Industry: -43,34%

GROSS MARGIN

100,00%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

-66,10%

Sector: -43,21% Industry: -43,21%

P/EBITDA

-9,16

Sector: -3,13 Industry: -3,13

P/EBIT

-8,64

Sector: -3,41 Industry: -3,41

P/ASSETS

1,62

Sector: 1,29 Industry: 1,29

VPA

8,56

Sector: 1,80 Industry: 1,80

LPA

-2,23

Sector: -2,09 Industry: -2,09

EQUITY / ASSETS

0,75

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

63,01%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-3,57%

Sector: - Industry: -

ARCT indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%

comparison of ARCT with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history ARCT dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Arcturus Therapeutics

Arcturus Therapeutics Holdings Inc.

Average user rating I10

4.0 (1 people)

Estados Unidos

17 years

Foundation: 2008

Year of debut on the stock exchange - - year

88

Employees

The Company Arcturus Therapeutics Holdings Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 499,77 Milhões, having a net worth of $ 231,05 Milhões.

With a total of 88 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 109,80 Milhões, which generated a loss in the amount of $ -60,16 Milhões.

As for its main indicators, the Company has a P/E ratio of -8,31, a P/B ratio of 2,16 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker ARCT.

Market value

US$ 499,77 Milhões

Net worth

US$ 231,05 Milhões

US$ 231.050.000,00

Assets

US$ 309,27 Milhões

US$ 309.270.000,00

Total Number of Shares

27,00 Milhões

27.000.000

Average Daily Trading Volume

US$ 561,59 Thousand

US$ 561.589,42

Sector

Cuidados de saúde

Industry

Biotecnologia

ARCT

ARCT revenue and profits

ARCT results

DRAG THE FRAME TO SEE MORE DATA

ARCT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of Arcturus Therapeutics (ARCT) today?

The price of Arcturus Therapeutics (ARCT) today is R$ 95,07, with a variation of -18.19% compared to the last year. The price of Arcturus Therapeutics (ARCT) started the year trading around R$ 91,98 and today it is at R$ 95,07. Follow the real-time price chart, the historical price of Arcturus Therapeutics (ARCT), and stock data from Ibovespa and international markets.

When does Arcturus Therapeutics (ARCT) pay dividends?

Arcturus Therapeutics (ARCT) did not distribute dividends in the last year.

Arcturus Therapeutics (ARCT) is it worth it?

Currently, Arcturus Therapeutics (ARCT) is priced at R$ 95,07, with a P/E of -8,31%, representing a deviation of -11,65% from its historical average P/E. In the last year, the stock showed a variation of -18.19% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -18,19%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Arcturus Therapeutics (ARCT)?

Investing in shares of Arcturus Therapeutics (ARCT) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Arcturus Therapeutics (ARCT) yield today?

The yield of Arcturus Therapeutics (ARCT) was 17,40% in the last month, -18,19% in the last year and -66,46% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Arcturus Therapeutics (ARCT) today, the total investment would be based on the current price of R$ 95,07.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 7.777,41
In 5 years: R$ 3.188,54
In 10 years: 3.102,03

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ARCT

Arcturus Therapeutics Holdings Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of ARCT

check out the fundamentals of Arcturus Therapeutics shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Arcturus Therapeutics

Arcturus Therapeutics Holdings Inc.

Estados Unidos

17 years

88

PROFIT X PRICE ARCT

ARCT results

ARCT cash flow

evolution of assets - ARCT

ARCT balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80